Delivery Order SPE2DB22D3016-SPE2DB25FBDR4
Award Date 7/31/25
Potential Completion Date 8/21/25
Potential Value $108K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,440.70 for XOLAIR 150 mg/mL syringes, with an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract representing a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,601.70 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes. This competitively awarded, firm fixed-price contract was issued on July 23, 2025, with an ultimate completion date of August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. XOLAIR (omalizumab) is a monoclonal antibody...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $21,610.20 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/mL syringes on July 28, 2025, with an ultimate completion date of August 18, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location in the same municipality. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 MG/1.2 ML Powder vials under a firm fixed-price contract. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. XOLAIR (omalizumab) is a monoclonal antibody therapy commonly used for treating...
- The Defense Logistics Agency awarded a delivery order valued at $25,932.24 to AmerisourceBergen Drug Corp for the supply of Xolair 150 mg/mL syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by August 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and...
- The Defense Logistics Agency awarded a $3,601.70 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for Xolair 150 mg/mL syringes, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,203.40 to AmerisourceBergen Drug Corp for XOLAIR 150 mg/ml syringes. The contract is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and was awarded on July 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award is issued without a set-aside designation, indicating it was competitively awarded. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xolair 75 mg/0.5 ml syringes with a ceiling value of $1,080.54 and a firm fixed price structure. This delivery order is non-set-aside and represents a competitively awarded contract with an ultimate completion date of August 11, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 28, 2025, valued at $6,376.64 for Xolair 300 mg/2 mL auto-injector units. This firm fixed price, competitive delivery order is funded by the Defense Logistics Agency (DLA) and will be performed at the awardee's Conshohocken facility, with an ultimate completion date of August 18, 2025. No set-aside provisions were applied to this award. This delivery...
- This delivery order, awarded July 28, 2025, to AmerisourceBergen Drug Corp represents a competitively awarded, non-set-aside contract for the procurement of XOLAIR 150MG/ML syringes with a ceiling value of $2,161.05. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. XOLAIR (omalizumab) is a monoclonal antibody...